PopPK for Voriconazole in pediatrics
Indication: Invasive aspergillosis and other serious pediatric fungal infections
Interactive pediatric voriconazole population PK simulator for invasive fungal infections. Uses a two-compartment model with Michaelis-Menten elimination plus CYP2C19 genotype, ALT, weight, and IV or oral dosing for this triazole inhibitor of fungal CYP51.
Drug Overview
Clinical Context
- Molecular Target
- Fungal CYP51 (lanosterol 14-alpha-demethylase)
- Drug Class
- Triazole antifungal
- Therapeutic Area
- Invasive fungal infections
- Indication
- Invasive aspergillosis and other serious pediatric fungal infections
- Route of Administration
- Intravenous and oral
Model Information
- Model Type
- Population PK (2-compartment Michaelis-Menten)
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for PopPK for Voriconazole in pediatrics allows you to explore concentration-time profiles under different dosing scenarios. The underlying Population PK (2-compartment Michaelis-Menten) model characterizes the pharmacokinetics of this triazole antifungal following intravenous and oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the PopPK for Voriconazole in pediatrics PK simulator?
This is a free, interactive pharmacokinetic simulator for PopPK for Voriconazole in pediatrics used in Invasive aspergillosis and other serious pediatric fungal infections. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does PopPK for Voriconazole in pediatrics belong to?
PopPK for Voriconazole in pediatrics is classified as a Triazole antifungal that targets Fungal CYP51 (lanosterol 14-alpha-demethylase). It is used in the Invasive fungal infections therapeutic area.
What route of administration does this model simulate?
This simulator models Intravenous and oral administration of PopPK for Voriconazole in pediatrics. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Population PK (2-compartment Michaelis-Menten) model. This model characterizes the time-course of drug concentrations following dosing.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Ready to Simulate?
Launch the PopPK for Voriconazole in pediatrics simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community